KLF10, on the other hand, transcriptionally represses EGFR and inhibits invasion and metastasis in vitro and in an orthotopic mouse tumor model [138], and KLF10 loss is downregulated in invasive human BC [133, 139]. This evidence concerns the gene EGFR and breast cancer.